Cyclacel Pharmaceuticals – Cell Cycle Inhibitor Study in Solid and Blood Cancers
Returning guest, Spiro Rombotis, President and CEO of Cyclacel Pharmaceuticals, a veteran of the industry and a developer of novel therapies that target...
5346 articles
Returning guest, Spiro Rombotis, President and CEO of Cyclacel Pharmaceuticals, a veteran of the industry and a developer of novel therapies that target...
Jeannette Bankes, President & GM, Global Surgical Franchise at Alcon, a global leader in eyecare, discusses sustainability and Alcon’s recently releas...
Andrea Bozoki, Division Chief and Professor of Memory and Cognitive Disorders at the University of North Carolina at Chapel Hill, and Susan Dickinson, C...
Returning guest, Rebecca Seidel, President, Cardiac Ablation Solutions Operating Unit at Medtronic discusses the recent acquisition of Affera, Inc, a me...
Michael Miller, MD, FACC, FAHA, Chief of Medicine at the Corporal Michael J. Learn more on Health Professional Radio.
Shannon Westin, MD, MPH, FACOG, gynecologic oncology physician at Lyndon Baines Johnson Hospital and a Professor in the Department of Gynecologic Oncolo...
Tanya Dorff, medical oncologist and section chief, Genitourinary Disease Program at City of Hope, a leading-edge cancer research and treatment organizat...
Sara Koenig, Ph.D., assistant professor of physiology and cell biology at The Ohio State University College of Medicine, discusses a discovery of rare g...
Nadim Ahmed, President and CEO of Cullinan Oncology, a clinical-stage biotechnology company developing a diversified pipeline of potential first - and best-in-class targeted therapies for...
Tomasz George, Ph.D., Chief Scientific Officer at Virax Biolabs, a global biotechnology company that focuses on the detection and diagnosis of viral dis...